Predict Responders in mRNA Trials via Metabolomics
Biomarker-Driven mRNA Trials: How Discovery Metabolomics Finds the Responders Before Treatment Your Phase 2 mRNA therapeutic trial enrolled sixty patients. Twenty showed remarkable responses. Thirty had modest benefits. Ten showed no response at all. Now you’re...
Metabolomic Logic Behind MAT2A/PRMT5 Combinations
Two Targets, One Pathway: The Metabolomic Logic Behind MAT2A/PRMT5 Combination Therapies The next breakthrough in cancer treatment may come from attacking two targets within the same metabolic pathway. MAT2A and PRMT5 inhibitor combinations represent a new paradigm in...
Beyond Trial and Error: Multi-Omics for Cultured Meat Media Optimization
The Traditional Media Optimization Bottleneck If you’re developing cultured meat at scale, you know the frustration. Your cells grow well for the first 48-72 hours, then productivity crashes. You suspect the media formulation, but identifying the limiting...